Business Context and Reporting Period
This Form 8-K is filed by Nemus Bioscience, Inc. (not Skye Bioscience, Inc.) on July 11, 2017. The report addresses a failed closing of a previously announced securities purchase agreement and the company's subsequent actions regarding the transaction.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or debt levels. The only financial figure disclosed relates to a specific transaction:
- Transaction Value: $20,000,000 (aggregate gross proceeds).
- Security Type: 1,000,000 shares of Series E Preferred Stock.
- Price Per Share: $20.00.
- Counterparty: Schneider Finance LLC (an affiliate of Schneider Brothers Ltd.).
Material Changes and Events
The primary event reported is the failure of the Purchaser to fund the transaction by the contractual deadline of July 10, 2017, at 1:00 pm Pacific Time. Consequently, the sale of the Preferred Shares did not close as originally scheduled. The company notes that no conditions precedent remained unmet prior to the deadline.
Outlook, Management Commentary, and Contingencies
Management intends to continue working with the Purchaser to close the transaction either directly or through the exercise of a $20 million guaranty. This guaranty, provided by SB Securities Ltd. (an affiliate of Schneider Brothers Ltd.), stipulates that the full purchase price must be paid within 90 days of exercise if the Purchaser defaults. The company has issued a press release regarding this development.
Investor Verification Checklist
- Verify the status of the $20 million guaranty and whether the company has formally demanded payment from SB Securities Ltd.
- Confirm if the transaction has been renegotiated or if the company is pursuing legal remedies for the breach of the May 3, 2017 agreement.
- Review the full text of the Financial Guarantee (Exhibit 99.1) for specific terms regarding the 90-day payment window and default conditions.
- Check for subsequent filings to determine if the funding was eventually received or if the deal was terminated.